Theralink Technologies (THER) Stock Price, News & Analysis
Company Description
Theralink Technologies (OTC Link: THER) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $615.1K.
For FY2023, Theralink Technologies reported revenue of $607K and diluted earnings per share of -$0.01.
This page collects what Stock Titan holds for THER, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Theralink Technologies (THER) stock last closed at $0.0000. At a market capitalization of $615.1K, THER is classified as a micro-cap stock with approximately 6.2B shares outstanding.
THER Rankings
Latest News
Theralink Technologies has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, management. View all THER news →
SEC Filings
Financial Highlights
Theralink Technologies generated $607K in revenue in FY2023, retaining a 79.2% gross margin, and operating income reached -$9.0M (-1479.8% operating margin). Diluted earnings per share stood at -$0.01. The company generated -$5.8M in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
THER Company Profile & Sector Positioning
Theralink Technologies (THER) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing THER often look at related companies in the same sector, including SYBLEU Inc (SYBE), Regen Biopharma (RGBP), Bio-Path Hldgs Inc (BPTH), Sqz Biotechnologies Co (SQZB), and Emmaus Life Scie (EMMA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate THER's relative position within its industry.